CytoSorbents Corporation (CTSO)

[raptorjockey]

On several occasions during the question and answer periods of the quarterly web casts, Dr Chan was asked directly what the capacity was of the manufacturing facility. He would not give a specific number, however, he did say that the capacity was large enough to handle the projected expansion of sales for a couple of years. I don't think he was getting squeezed for product as the uses are still under 50,000 units so far. I believe the expansion plans were accomplished well ahead of need, and also incorporated the need to supply HemoDefend. According to Mr. Capponi, "We plan to utilize the current manufacturing facility, leveraging existing assets and infrastructure, to produce HemoDefend clinical devices for the planned HemoDefend U.S. pivotal trial to start in late 2018-early 2019". We were told that there was plenty of capacity to supply the current needs, if we were to find out otherwise, that could have been a potential fatal mistake on Dr Chans credibility and he is too smart to do that. In my opinion, the new facility addressed the need for future capacity and also addressed the need for expanding product line. This being said, I admit I was caught flatfooted on the recent Russell reconstitution thing. Never came face to face with that til this year. Lol... Maybe an old dog, but still learning!